Dr. Brian Chen's research has examined the tradeoffs between moral hazard and efficiencies in the integration of physician and non-physician medical services in the presence of asymmetric information. He has looked at a policy intervention in Taiwan that prohibited self-referrals of patients to physician-owned pharmacies unless the physician group integrated pharmacy services into the clinic by hiring an onsite pharmacist. He found that the policy reduced drug expenditures by close to thirty percent among physicians that did not have an onsite pharmacist. However, these physicians responded by increasing the overprovision of diagnostic services not covered by the policy, thereby reducing the effectiveness of the policy. Forty-five percent of the clinics that did not have an onsite pharmacist prior to the policy hired one subsequent to the implementation of the policy. Overall, after integration, the policy applied to only seventeen percent of clinics, and only reduced average discretionary expenditures by about two-point-five percent. Chen's research also shows that despite the reduction in drug utilization, patients treated at clinics without an onsite pharmacist did not have greater observable adverse health events than patients treated at integrated clinics. His results show that moral hazard costs of self-referral incentives are large, that the “safe harbor” exemption severely reduces the effectiveness of the policy, and that the exemption explains much of the recent integration of ancillary services into physician offices.

Dr. Brian Chen recently completed his Ph.D. in business administration in the Business and Public Policy Group at the Haas School of Business, University of California at Berkeley. He received a Juris Doctor from Stanford Law School in 1997, and graduated summa cum laude from Harvard College in 1992.

On January 1, 2010, China and the ten-member Association of Southeast Asian Nations (ASEAN) finally, formally launched a China-ASEAN Free Trade Agreement (CAFTA) that encompasses nearly two billion people engaged in trade worth some $200 billion. For China the agreement is a way of securing supplies of raw materials, while the ASEAN countries hope the agreement will open opportunities in China's huge domestic market. When CAFTA  was first signed in November 2002, Beijing promised that Southeast Asia would reap an “early harvest” of its benefits. Yet the Southeast Asian response to CAFTA in the agreement’s first year has been less than enthusiastic, especially in the Philippines and Indonesia. Is CAFTA a bonanza? A blunder? Something in between? Prof. Mendoza will assess the agreement, its implementation, and the implications for China’s role and image in Southeast Asia going forward.

Amado M. Mendoza, Jr. is a leading policy scholar in the Philippines, where he also serves as the treasurer of Economic, Social, and Cultural Rights (ESCR) Asia, Inc., an NGO dedicated to the promotion of socio-economic and cultural rights. He is the Philippines’ lead contributor to the soon-to-be-released 2010 Global Integrity Report on governance and corruption. Other subjects of his current research include Asian regional integration; Asian summitry and economic crisis management; Philippine economic diplomacy; and China-Taiwan relations within a regional context. In addition to his academic career, he has a background in journalism, banking, and development.

Asian Biotech:  Ethics and Communities of Fate is the title of a new book that Prof. Ong has co-edited with Nancy N. Chen.  It offers the first overview of Asia’s emerging initiatives in the biosciences.  Its case studies include blood collection in Singapore and China; stem-cell research in Singapore, South Korea, and Taiwan; genetically modified foods in China; and clinical trials in India.  Such projects vary by country, as do the policies that are associated with them.  Discernible nevertheless is a significant trend toward state entrepreneurialism in Asian biotechnology.  Prof. Ong will also explore how political thinking and ethical reasoning are converging around the biosciences in Asia.  Copies of Asian Biotech will be available for signing and purchase at the talk.

Aihwa Ong studies how the interactions of capitalism, technology, politics, and ethics crystallize global situations, frame spaces of problematization, and generate situated solutions.  With these matters in mind, she has done field research in Southeast Asia, Southern China, and California.  A forthcoming volume is Worlding Cities:  Asian Experiments and the Art of Being Global.  Prior publications include Spirits of Resistance and Capitalist Discipline (2nd ed., 2010); Privatizing China:  Socialism from Afar (co-edited, 2008); Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems (co-edited, 2005); Flexible Citizenship:  The Cultural Logics of Transnationality (1999); Neoliberalism as Exception:  Mutations in Citizenshipand Sovereignty (2006); and Buddha is Hiding:  Refugees, Citizenship, the New America (2003).  Prof. Ong has received many awards and has lectured at universities around the world.  She chairs of the US National Committee for the Pacific Science Association.  Her 1982 PhD is from Columbia University.

With a territory consisting of 36,000 square kilometres and a population of 23 million, the Republic of China (ROC) on Taiwan, Penghu, Jinmen and Mazu had, in 1970, the year prior to its withdrawal from the United Nations (UN), a population larger than two thirds of the countries in the world. In 1996, its population exceeded that of three quarters of the member nations of UN. However, the question of Taiwan being a nation in the international order is, strangely, still debated. To enquire into this delicate issue, Dr. Man-houng Lin will address to what extent the statehood of the ROC on Taiwan has or has not been secured by the Treaty of Peace between the Republic of China and Japan, singed and turned effective in 1952, and often referred to as the “Taipei Treaty.” (Taibei heyue) She will also illustrate that not only the People’s Republic of China, but also the Taiwanese in general have been unclear about Taiwan’s status as a sovereign state on the world stage. Meanwhile, in this special seminar Dr. Lin will further depict the background of the Taipei Treaty in terms of the long-term history of the Asian Pacific region. She will show how the Cold War made the Taipei Treaty, and ironically, how the ideological attachment of Taiwan with the Chinese mainland has also blurred this treaty. 

Man-houng Lin received her Ph.D. in History and East Asian Languages from Harvard University. She has been a Senior Research Fellow at the Institute of Modern History, Academia Sinica since 1990, and Professor at the Department of History, National Taiwan Normal University since 1991. Her research interests include treaty ports and modern China, native opium of late Qing China, currency crisis and early nineteenth-century China, and Taiwanese merchants' overseas economic networks during the Japanese colonial period. She has published 5 books and about 70 articles in Chinese, English, Japanese, and Korean. From May 2008 to December 2010, Dr. Lin was President of the Academia Historica, the Republic of China (Taiwan).